The Gross Margin of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (600613.SS) is 49.93%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 49.93% |
2022-12-31 | 52.90% |
2021-12-31 | 60.13% |
2020-12-31 | 59.16% |
2019-12-31 | 62.88% |
2018-12-31 | 60.77% |
2017-12-31 | 60.09% |
2016-12-31 | 66.13% |
2015-12-31 | 74.03% |
2014-12-31 | 78.74% |